Clinical Utility of Liquid Biopsy to Identify Genomic Heterogeneity and Secondary Cancer Diagnoses: A Case Report

Liquid biopsy is a valuable tool in advanced and metastatic cancers for detection of genomic alterations in tumors that facilitate personalized targeted therapy approaches. Analyzing circulating tumor DNA (ctDNA) using next-generation sequencing (NGS) provides an opportunity to detect tumor genomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemenway, Gregory, Tierno, Marni B., Nejati, Reza, Sosa, Romina, Zibelman, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921912/
https://www.ncbi.nlm.nih.gov/pubmed/35350808
http://dx.doi.org/10.1159/000521841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921912/
https://www.ncbi.nlm.nih.gov/pubmed/35350808
http://dx.doi.org/10.1159/000521841

Ejemplares similares